滋肝益肾汤联合西药治疗糖尿病视网膜病变玻璃体切除术后临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R781.6+4

基金项目:

河南省医学科技攻关计划项目(LHGJ2019083)


Clinical Study on Zigan Yishen Decoction Combined with Western Medicine for Patients After Vitrectomy for Diabetic Retinopathy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察滋肝益肾汤联合西药治疗糖尿病视网膜病变玻璃体切除术后患者的疗效。方法:选取 96 例肝肾亏虚型糖尿病视网膜病变患者作为研究对象,按照随机数字表法分为对照组和联合组各48 例。2 组 均行玻璃体切除术,术前1 周均在玻璃体腔内注射雷珠单抗注射液,术后使用妥布霉素地塞米松眼膏、氯替泼 诺混悬滴眼液治疗,联合组加予滋肝益肾汤治疗。治疗前及治疗2 个月后检测2 组患者的血清血管内皮生长因 子(VEGF)、骨形成蛋白-2 (BMP-2)、血糖[餐后2 h 血糖(P2hBG)、空腹血糖(FBG)、糖化血红蛋 白(HbA1c)],比较2 组的视力改善情况、中医证候疗效及不良反应发生率。结果:治疗后,联合组中医证 候疗效总有效率(87.50%) 高于对照组(64.58%), 差异有统计学意义(P<0.01)。联合组视力改善 率(85.42%) 高于对照组(62.50%),差异有统计学意义(P<0.05)。2 组血清VEGF、BMP-2 及P2hBG、 FBG、HbA1c 水平均较治疗前下降(P<0.05),联合组5 项指标值均低于对照组(P<0.05)。2 组不良反应发 生率比较,差异无统计学意义(P>0.05)。结论:滋肝益肾汤联合西药治疗糖尿病视网膜病变玻璃体切除术后 患者可有效改善血管内皮功能及控制血糖水平,改善视力,安全有效。

    Abstract:

    Abstract: Objective: To observe the curative effect of Zigan Yishen Decoction combined with western medicine for patients after vitrectomy for diabetic retinopathy. Methods:A total of 96 cases of patients with diabetic retinopathy of liver-kidney depletion type were selected as the study subjects and divided into the control group and the combination group according to the random number table method, with 48 cases in each group. Both groups were treated with vitrectomy. One week before the operation, Ranibizumab Injection was injected into the vitreous. After the operation,both groups were treated with Tobramycin Dexamethasone Eye Ointment and Loteprednol Etabonate Ophthalmic Suspension,and the combination group was additionally treated with Zigan Yishen Decoction. Before treatment and after twomonth treatment,the vascular endothelial growth factor(VEGF) and bone morphogenetic protein-2(BMP-2) in serum,and blood glucose including postprandial 2-hour blood glucose(P2hBG),fasting blood glucose (FBG) and hemoglobin A1c(HbA1c) in the two groups were detected. The improvement of vision, curative effect of traditional Chinese medicine(TCM) syndromes and incidence of adverse reactions were compared between the two groups. Results: After treatment, the total curative effect rate of TCM syndromes was 87.50% in the combination group,higher than that of 64.58% in the control group,the difference being significant(P<0.01). The improvement rate of vision was 85.42% in the combination group, higher than that of 62.50% in the control group, the difference being significant(P<0.01). The levels of VEGF and BMP-2 in serum,and P2hBG,FBG and HbA1c in the two groups were decreased when compared with those before treatment(P<0.05), and the five values in the combination group were lower than those in the control group(P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups(P>0.05). Conclusion:Zigan Yishen Decoction combined with western medicine for patients after vitrectomy for diabetic retinopathy can effectively improve vascular endothelial function and control levels of blood glucose, and improve vision,which is safe and effective.

    参考文献
    相似文献
    引证文献
引用本文

孙耀成,张珍.滋肝益肾汤联合西药治疗糖尿病视网膜病变玻璃体切除术后临床研究[J].新中医,2023,55(2):85-89

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-01-29
  • 出版日期:
文章二维码